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IT has previously been shown that the mice from the closed colony kept at
this Institute react in two distinct ways to theintraperitonealinjection ofElirlich's
ascites carcinoma (Hartveit, 1961a). About half of them are highly sensitive to
some factor in the tumour. They produce a haemorrhagic ascites and die soon
after transplantation. The others are less sensitive. They have significantly
less blood in their ascites and survive longer (see also Hartveit, 1961b). Thus
approximately half of the mice used here can be expected to produce a haemor-
rhagic ascitesfollowing theintraperitonealinjection ofEhrhch's ascites carcinoma.
But this haemorrhagic reaction does not occur in any of the mice until between
3 and 6 days after transplantation. By 6 days the reaction is present in ap-
proximately 50 per cent of the animals, i.e. those that could be expected to
react to the tumour in this way (Hartveit, 1963).
Thepresentexperiment wasdesigned to see if an increase in the dose oftumour
given would increase this haemorrhagic reaction.
MATERIAL AND METHODS
The mice and the tumour used were similar to those used in previous experi-
ments (Hartveit, 1961b), the tumour now being in its 166th transplant genera-
tion.
Two groups of ten male and ten female mice were set up. The mice in group
I were eachgiven 0-I ml. ofEhrhch's ascites carcinomaintraperitoneaRy (tumour
cell count 1,440,000/mm,3., tumour blood content-2 per cent). The tumour
came from a mouse of the previous transplant generation. The mice in group II
each received 0-4 ml. of the same tumour intraperitoneafly.
The mean starting weight of the animals in both groups was the same, being
21-9 ± 0-7 g. for the males and 18-5 ± 0-4 g. for the females.
Three days after transplantation the mice in both groups were kined and the
tumour ascitedremoved. Films were made from theascites, airdried, and stained
with Leishman's stain. In making the films care was taken to use drops of
uniform size and to keep the covershps used to spread the drops at a constant
angle-it was hoped that in this way films of comparable thickness would be
obtained. The number of erythrocytes per 5 consecutive high power fields was
then counted on each slide, i.e. 5 fields/mouse.
RESULTS
The results are summarized in Table I which shows that a significantly greater
amount of blood was present at 3 days in the tumours of mice that had been
given 0-4 ml. of Ehrlich's ascites carcinoma (group II) than in those that had
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been given one quarter of that dose (group 1). The sex differences within the
groups were not significant. This is in keeping with previous findings (Hartveit,
1961a).
TABLEI.-The, Mean Tumour Blood Content (:.), see Text, at 3 Days in Mice given
Different Doses ofEhrlich's Ascites Carcinoma Intraperitoneally.
Group Tumour dose
I 0. I mi.
II 0
- 4 ml.
Sex Number
s 10
? 10
d + y 20
s 10
? 10
d + y 20
7
8- 8
1.5
5.1
102
- 5
73- 3
87
- 9
SDI
14-5
2
- 9
11.0
115.0
33-0
85- 0
Fig. I gives the individual values in the two groups. The broken line across
this histogram represents the limit above which the blood content is considered
to be significantly higher than the mean content found in group I-Le. the mean
plus twice its standard deviation (5 + 22). From this it can be seen that the
blood content in 10 (50 per cent) of the mice in group 11 lay below this hne,
while that in the other mice in this group lay above it.
Table II gives the results ofdividing group 11 into subgroups, group a being those with a tumour blood content that lay below the line described, group b
those with values above the line. The blood content in these 2 subgroups differs
in
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FIG. I.-The tumour blood content in mice given 0-1 n-d. of Ehrlich's ascites carcinoma
intraperitoneally (group 1) and in those given 0-4 ml. of the same tumour by the same
route (group II).480 F. HARTVEIT
significantly. The total series has been used as the sex difference in the blood
content within the group is notsignificant (vide8upra).
TABLEII.-The, Difference in Mean Tumour Blood Content (T) in GrOUP8
IIa and IIb (see text).
Group Number SD.. SE-Ta-5.b t p
Ila I0 159- 3 68- 0
- 5 -5 0-001 > P Ilb 10 16-5 5- 7 21 6
Table III gives the blood content in group I and group Ilb, and shows that
the difference between these groups is also significant.
TABLEIII.-The Difference in Mean Tumour Blood Content (7) in GrOUP8
I and Ilb (see text).
Group Number m SDI SEX][-XlIb t p
I 20 5-1 11-0 3. i 3-7 0-001>P lIb 10 16-5 5- 7
DISCUSSION
It has previously been shown that the blood content of the Ehrlich ascites
carcinoma is a measure of the host response to this tumour homograft (Hartveit,
1961b). As mentioned above, the mice used here react in two distinct ways to
the intraperitoneal transplantation of this tumour. About half of them are
sensitive to some factor in the tumour and produce a haemorrhagic ascites. The
others are not sensitive to this factor and have significantly less blood in their
ascites. Further, the haemorrhagic reaction does not occur in any of the mice
until after the third day following the transplantation of 0-1 ml. of the tumour,
while the 50 per cent that could be expected to show a haemorrhagic ascites do
so by the 6th day (Hartveit, 1963).
Anincrease in the dose oftumourused, i.e. an increase in theantigenicstimulus,
if it led to an increase in the tumour blood content could do so in any, or all, of
three ways. Firstly, it might induce the blood to form sooner after transplanta-
tion. Secondly, the mice that react to the lower dose might respond more
violently, and thirdly, the mice that do not react might be induced to do so. All
these possibilities seem likely when it is remembered that the tumour blood
content is inversely proportional to the survival time of the mice (Hartveit,
1961a) and that the survival time decreases with increasing tumour cen dose
(Klein, 1950).
The present experiment shows that an increase in the tumour cell dose does
lead to an increase in the tumour blood content. In addition it appears to do so
in aR the three ways mentioned above.
The mice in both groups were killed on the same day-but those that had
received 0-4 ml. of tumour ascites (group II) showed a significantlybighei tumour
blood content than those that had beengiven 0-I ml. ofthe same tumour (group I)
(Table I).
Considering group II more closely it wiR be seen that some of the mice pro-
duced grossly haemorrhagic ascites while in others the blood staining was less.
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raised
" the confidence limit of the mean blood content in group I plus twice its
standard deviation was chosen. Any values above this woudd differ significantly
from the mean that could be expected if no increase in blood content had taken
place. If we make use of this dividing line, the broken line on the histogram
(Fig. 1), it appears that in I0 of the animals the blood content was above this
level. Thus half of the mice have been induced to react more violently (group
Ila). The other I0 mice did not react so violently (Ilb)-their values lay below
the confidence limit. But they did react and, as Table III shows, the tumour
blood content in these mice (Ilb) was significantly greater than that in group 1.
These findin-as su-a est that the mice in group Ila represent those that could
have been expected to react to the antigenic stimulus while those in group Ilb
are those that do not normally do so. This idea is supported by the finding
that the blood contents in these two subgroups of group II differ significantly
(Table 11). Thus the mice fall into two distinct groups as regards the tumour
blood content th-ree days after the intraperitoneal injection of 0.4 ml. of tumour
there is no gradual merger of one group into the other.
This finding, in conjunction with the previous report that these mice fall into
two distinct groups as regards their survival time, their tumour blood content at
death following the intraperitoneal injection of 0.1 ml. of the tumour, and hence
their reaction to the tumour homograft (Hartveit, 1961a), supports the idea that
two distinct populations are present in this closed colony. At present it is not
possible to separate them before the injection of the tumour.
The present experiment can thus be said to have shown that an increase in
the antigenic stimulus given can increase, both in velocity and extent, the
haemorrhagic response in mice that could be expected to produce a haemorrhagic
ascites, and can, in addition, induce a haemorrhagic response in mice that would
not react in this way to a lower tumour dose.
It has been shown in previous work (Hartveit, 1962a, b) that the subcutaneous
injection ofEhrlich's ascites carcinoma combined with Freund'sadjuvant increases
the blood content of the intraperitoneal tumour in both these ways-i.e. more
blood is formed in the mice that could be expected to produce a haemorrhagic
ascites and blood is also present in those that could be expected to lack blood.
The finding that simple increase in the dose of antigen used has the same effect
adds support to the idea that combination with Freund's adjuvant did in fact
increase the antigenicity of the tumouir.
SUMMARY
An increase in the dose ofEhrlich's ascites carcinomainjectedintraperitoneally from 0-I ml. to 0-4 ml. leads to an increase in the blood content of the tumour
ascites 3 days after transplantation. This increase is significant in aR the mice,
but the extent of the reaction varies and the blood content shows a markedly bimodal distribution. This finding supports the previous evidence that the mice
from this closed colony fall into 2 distinct groups as regards their reaction to the
intraperitoneal injection of this tumour.
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